Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone demethylase UTX is a therapeutic target for diabetic kidney disease
Hong Chen, Yixue Huang, Zhu Xiu-qin, et al.
The Journal of Physiology (2018) Vol. 597, Iss. 6, pp. 1643-1660
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

UTX Responds to Nanotopography to Suppress Macrophage Inflammatory Response by Remodeling H3K27me3 Modification
Hengji Jia, He Zhang, Dingqiang Mo, et al.
Advanced Science (2025)
Open Access
GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes via Preserving H3K27 Methylation and Reducing Ferroptosis
Kai Xu, Xiang Liu, Bin Wen, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 16
α‐Ketoglutarate–Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus
Erica N. Montano, Moumita Bose, Lihong Huo, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 3, pp. 396-410
Open Access | Times Cited: 9
Loss of histone lysine methyltransferase EZH2 confers resistance to tyrosine kinase inhibitors in non-small cell lung cancer
Chuntao Quan, Yuchen Chen, Xiaomu Wang, et al.
Cancer Letters (2020) Vol. 495, pp. 41-52
Closed Access | Times Cited: 21
The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation
Peir‐Haur Hung, Yung‐Chien Hsu, Tsung‐Hsien Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9407-9407
Open Access | Times Cited: 13
The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy
Lijuan Chen, Xin-Yang Xu, Xiao-Dan Zhong, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106409-106409
Closed Access | Times Cited: 8
Histone modification in podocyte injury of diabetic nephropathy
Simeng Wang, Xinyu Zhang, Qinglian Wang, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 10, pp. 1373-1386
Closed Access | Times Cited: 12
Demethylation of H3K9 and H3K27 Contributes to the Tubular Renal Damage Triggered by Endoplasmic Reticulum Stress
Paula Díaz-Bulnes, María Laura Sáiz, Viviana Corte-Iglesias, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1355-1355
Open Access | Times Cited: 11
PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury
Chao Wang, Mingrui Xiong, Chen Yang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 16028-16042
Closed Access | Times Cited: 16
hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy
Shoujun Bai, Xiaoyan Xiong, Bo Tang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 13
Histone demethylase UTX aggravates acetaminophen overdose induced hepatotoxicity through dual mechanisms
Yixue Huang, Yunhao Xie, Dong Yang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106021-106021
Closed Access | Times Cited: 12
Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19
Chengyu Liu, Wanyao Yan, Jiajian Shi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 9
Functioning and mechanisms of PTMs in renal diseases
Zhenzhen Liu, Jian Yang, Minghui Du, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Endothelial–Mesenchymal Transition Switch and Diabetic Kidney Disease
Tomohito Doke, Petter Bjornstad
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 6, pp. 670-672
Closed Access | Times Cited: 1
Si-Ni-San ameliorates cholestatic liver injury by favoring P. goldsteinii colonization
Fanghong Li, Qi Han, Yajie Cai, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118804-118804
Closed Access | Times Cited: 1
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)
Peng Qu, Lanfang Li, Qi Jin, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 5
Closed Access | Times Cited: 1
Applicability of Mesenchymal Stem Cell-Derived Exosomes as a Cell-Free miRNA Therapy and Epigenetic Modifiers for Diabetes
Shikha Sharma, Ramesh Bhonde
Epigenomics (2023) Vol. 15, Iss. 24, pp. 1323-1336
Closed Access | Times Cited: 3
KDM6A mutations promote acute cytoplasmic DNA release, DNA damage response and mitosis defects
Julian Koch, Alexander Lang, Patcharawalai Whongsiri, et al.
BMC Molecular and Cell Biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Histone demethylase KDM5A regulates the functions of human periodontal ligament stem cells during periodontitis via the miR-495-3p/HOXC8 axis
Fang Niu, Jing Xu, Yujuan Yan
Regenerative Therapy (2022) Vol. 20, pp. 95-106
Open Access | Times Cited: 5
Epigenetic Landscape Changes Due to Acupuncture Treatment: From Clinical to Basic Research
Hao Hong, Xinyue Jing, Shu-Bao Liu, et al.
Chinese Journal of Integrative Medicine (2020) Vol. 26, Iss. 8, pp. 633-640
Closed Access | Times Cited: 4
Unraveling the epigenetic landscape of glomerular cells in kidney disease
Beatriz Maria Veloso Pereira, Yash T. Katakia, Syamantak Majumder, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 6, pp. 785-803
Closed Access | Times Cited: 4
Altered expression, but small contribution, of the histone demethylase KDM6A in obstructive uropathy in mice
Lisa Y. Q. Hong, Emily S. H. Yeung, Duc Tin Tran, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 9
Open Access | Times Cited: 1
The potential of epigenetic compounds in treating diabetes
Adriana Fodor, Angela Cozma, Adela Sitar-Tăut, et al.
Elsevier eBooks (2023), pp. 517-564
Closed Access | Times Cited: 1
Phase Separation of Chromatin Structure-related Biomolecules: A Driving Force for Epigenetic Regulations
Jiao Wang, Yuchen Chen, Zixuan Xiao, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 553-566
Closed Access
DOT1L protects against podocyte injury in diabetic kidney disease through phospholipase C-like 1
Yepeng Hu, Shu Ye, Jing Kong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access

Scroll to top